论文部分内容阅读
目的观察参松养心胶囊与曲美他嗪联用治疗冠心病室性期前收缩的疗效。方法 66例冠心病室性期前收缩的患者随机分为二组,治疗组34例采用参松养心胶囊联合曲美他嗪治疗;对照组单用参松养心胶囊治疗。结果治疗4周后二组患者病情均有改善,治疗组总有效率88.2%,明显优于对照组71.9%(P<0.05);动态心电图改善情况,治疗组总有效率85.3%,对照组总有效率68.8%,二组比较差异有统计学意义(P<0.05)。结论参松养心胶囊与曲美他嗪联用治疗冠心病室性期前收缩有明显疗效。
Objective To observe the efficacy of Shensong Yangxin capsule combined with trimetazidine in the treatment of premature ventricular contractions in patients with coronary heart disease. Methods Sixty-six patients with premature ventricular contraction in patients with coronary heart disease were randomly divided into two groups. The treatment group was treated with Shensong Yangxin Capsule and trimetazidine. The control group was treated with Shensongyangxin Capsule alone. Results After 4 weeks of treatment, the patients in both groups improved their symptoms, and the total effective rate was 88.2% in the treatment group, which was significantly better than that in the control group (71.9%, P <0.05). The dynamic electrocardiogram was improved in the treatment group with a total effective rate of 85.3% The effective rate was 68.8%, the difference between the two groups was statistically significant (P <0.05). Conclusion Shensong Yangxin Capsule and trimetazidine combined treatment of coronary heart disease before ventricular contraction has a significant effect.